Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Expert Review of Endocrinology & Metabolism|January 28, 2025
Glucocorticoid therapy in classic congenital adrenal hyperplasia: traditional and new treatment paradigmsIrina Bancos, Hyunwoo Kim, Henry K Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.
Clinical Pharmacology and Therapeutics|July 2, 2010
Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivityS-H Chen, D Pei, W Yang, et al.
Blood|February 15, 1990
Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, S S Jeha, S Buescher, et al.
Cell Metabolism|January 2, 2009
The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolismLuoping Li, Xin Xie, Jun Qin, et al.
Blood Cancer Journal|February 18, 2017
The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemiaH M Eissa, Y Zhou, J C Panetta, et al.
The New England Journal of Medicine|December 22, 1988
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, S Buescher, H E Broxmeyer, et al.
Journal of Pediatric Hematology/Oncology|June 11, 1999
Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancerC A Mullen, D Petropoulos, W M Roberts, et al.
Cancer|July 3, 1999
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patientsC A Mullen, D Petropoulos, W M Roberts, et al.
Leukemia|September 11, 2009
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemiaN Hijiya, P Gaynon, E Barry, et al.
Pageof 7